Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin vs NovoLog in Type 2 Diabetes
NCT00624767Phase 2Completed
- Sponsor
- Nastech Pharmaceutical Company Inc.
- Start
- Mar 2008
- Primary completion
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of regular human insulin in type 2 diabetes mellitus (T2DM), sponsored by Nastech Pharmaceutical Company Inc.. Started Mar 2008; status: completed.
02
Drugs
regular human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00624767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624767.